Alzheimer's Prevention Initiative Generation Program: Development of an APOE genetic counseling and disclosure process in the context of clinical trials
Abstract Introduction As the number of Alzheimer's disease (AD) prevention studies grows, many individuals will need to learn their genetic and/or biomarker risk for the disease to determine trial eligibility. An alternative to traditional models of genetic counseling and disclosure is needed t...
Saved in:
| Main Authors: | Carolyn M. Langlois, Angela Bradbury, Elisabeth M. Wood, J. Scott Roberts, Scott Y.H. Kim, Marie‐Emmanuelle Riviere, Fonda Liu, Eric M. Reiman, Pierre N. Tariot, Jason Karlawish, Jessica B. Langbaum |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Alzheimer’s & Dementia: Translational Research & Clinical Interventions |
| Subjects: | |
| Online Access: | https://doi.org/10.1016/j.trci.2019.09.013 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacogenetics or predictive genetics? APOE testing blurs the lines
by: Stefania Zampatti, et al.
Published: (2025-07-01) -
Patients with Alzheimer's disease who carry the APOE ε4 allele benefit more from physical exercise
by: Camilla Steen Jensen, et al.
Published: (2019-01-01) -
Regional analysis of APOE polymorphism in Alzheimer’s disease in Spain
by: Ignacio Pardo-Pérez, et al.
Published: (2025-04-01) -
Prevalence of ApoE Alleles in a Spanish Population of Patients with a Clinical Diagnosis of Alzheimer’s Disease: An Observational Case-Control Study
by: Laura Bello-Corral, et al.
Published: (2024-11-01) -
APOE2 reduces risk of Alzheimer's disease by protection of lysosomes from lipid overloading
by: Jing Feng, et al.
Published: (2025-08-01)